Cohen JA - Search Results

1

Technology-enabled assessments to enhance multiple sclerosis clinical care and research.

Macaron G, Moss BP, Li H, Baldassari LE, Rao SM, Schindler D, Alberts JL, Weber M, Ayers M, Bethoux F, Boissy A, Chizmadia D, Conway DS, Fink C, Fox RJ, Gales S, Green B, Hara-Cleaver C, Jordan N, Mahajan KR, McGinley MP, Miller DM, Namey M, Rae-Grant A, Rensel M, Young H, Willis MA, Ontaneda D, Cohen JA, Bermel RA. Macaron G, et al. Among authors: cohen ja. Neurol Clin Pract. 2020 Jun;10(3):222-231. doi: 10.1212/CPJ.0000000000000710. Neurol Clin Pract. 2020. PMID: 32642324 Free PMC article.

2

Intrarater and interrater reliability of the MS functional composite outcome measure.

Cohen JA, Fischer JS, Bolibrush DM, Jak AJ, Kniker JE, Mertz LA, Skaramagas TT, Cutter GR. Cohen JA, et al. Neurology. 2000 Feb 22;54(4):802-6. doi: 10.1212/wnl.54.4.802. Neurology. 2000. PMID: 10690966

3

Multiple sclerosis: the importance of early recognition and treatment.

Fox RJ, Cohen JA. Fox RJ, et al. Among authors: cohen ja. Cleve Clin J Med. 2001 Feb;68(2):157-71. doi: 10.3949/ccjm.68.2.157. Cleve Clin J Med. 2001. PMID: 11220457 Free article.

4

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Marrie RA, Miller DM, Chelune GJ, Cohen JA. Marrie RA, et al. Among authors: cohen ja. Mult Scler. 2003 Dec;9(6):621-6. doi: 10.1191/1352458503ms971oa. Mult Scler. 2003. PMID: 14664477

5

Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.

Marrie RA, Chelune GJ, Miller DM, Cohen JA. Marrie RA, et al. Among authors: cohen ja. Mult Scler. 2005 Feb;11(1):69-75. doi: 10.1191/1352458505ms1110oa. Mult Scler. 2005. PMID: 15732269

6

Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, Balcer LJ. Baier ML, et al. Among authors: cohen ja. Neurology. 2005 Mar 22;64(6):992-5. doi: 10.1212/01.WNL.0000154521.40686.63. Neurology. 2005. PMID: 15781814 Clinical Trial.

7

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.

Fox RJ, Fisher E, Tkach J, Lee JC, Cohen JA, Rudick RA. Fox RJ, et al. Among authors: cohen ja. Mult Scler. 2005 Apr;11(2):140-5. doi: 10.1191/1352458505ms1142oa. Mult Scler. 2005. PMID: 15794385 Clinical Trial.

8

Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.

Fox RJ, Bethoux F, Goldman MD, Cohen JA. Fox RJ, et al. Among authors: cohen ja. Cleve Clin J Med. 2006 Jan;73(1):91-102. doi: 10.3949/ccjm.73.1.91. Cleve Clin J Med. 2006. PMID: 16444920 Free article. Review.

9

Multiple sclerosis: treating symptoms, and other general medical issues.

Goldman MD, Cohen JA, Fox RJ, Bethoux FA. Goldman MD, et al. Among authors: cohen ja. Cleve Clin J Med. 2006 Feb;73(2):177-86. doi: 10.3949/ccjm.73.2.177. Cleve Clin J Med. 2006. PMID: 16478042 Free article. Review.

10

Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study.

Miller DM, Cohen JA, Kooijmans M, Tsao E, Cutter G, Baier M. Miller DM, et al. Among authors: cohen ja. Mult Scler. 2006 Apr;12(2):180-6. doi: 10.1191/135248506ms1270oa. Mult Scler. 2006. PMID: 16629421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

729 results

Search Page

Filters